Abstract:Recent studies have reported that dietary fiber improved metabolic syndrome (MetS). However, the effects of fucoidans on MetS were still not clear. In this study, we evaluated the activity of fucoidan from Fucus vesiculosus (FvF) on attenuating MetS and first elucidated the underlying mechanism. In vitro, FvF treatment remarkably lowered the level of reactive oxygen species (ROS) compared with the sodium palmitate (PA)-induced insulin resistance (IR) group. The phosphorylation level of c-Jun N-terminal kinase (JNK) was significantly decreased, while phosphorylation of protein kinase B (pAkt) level increased, compared with that of the HepG2 cells treated with PA. Thus, FvF increased glucose consumption and relieved IR via ROS-mediated JNK and Akt signaling pathways. In addition, these changes were accompanied by the activation of adenosine 5'-monophosphate-ativated protein kinase (AMPK) and its downstream targets (e.g., HMG-CoA reductase (HMGCR), acetyl-CoA carboxylase (ACC), and sterol-regulatory element-binding protein-1c (SREBP-1C)), which improved lipid metabolism in IR HepG2 cells. In vivo, FvF improved hyperglycemia and decreased serum insulin level in mice with MetS. Furthermore, we evaluated the inhibition of glucose transport by in vitro (Caco-2 monolayer model), semi-in vivo (everted gut sac model) and oral glucose tolerance test (OGTT), which indicated that FvF could significantly reduce the absorption of glucose into the blood stream, thus it could improve blood-glucose levels and IR in mice with MetS. Moreover, FvF decreased serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) levels and liver lipid accumulation, while increased the serum high density lipoprotein cholesterol (HDL-C) level in mice with MetS. Therefore, FvF could be considered as a potential candidate for the treatment of MetS by alleviating IR, inhibiting glucose transportation, and regulating lipid metabolism.

Fucoidan from Sea Cucumber Cucumaria Frondosa Exhibits Anti-Hyperglycemic Effects in Insulin Resistant Mice Via Activating the PI3K/PKB Pathway and GLUT4.

Fucoidan from Sea Cucumber Protects Against High-Fat High-Sucrose Diet-Induced Hyperglycaemia and Insulin Resistance in Mice

Fucoidan Isolated from the Sea Cucumber Acaudina Molpadioides Improves Insulin Resistance in Adipocytes Via Activating PKB/GLUT4 Pathway

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

EFFECTS OF FUCOIDAN ISOLATED FROMACAUDINA MOLPADIOIDESON HEPATIC GLYCOGEN SYNTHESIS IN INSULIN RESISTANT MICEAND ITS MECHANISM

Fucosylated Chondroitin Sulfate from Sea Cucumber Improves Glucose Metabolism and Activates Insulin Signaling in the Liver of Insulin-Resistant Mice.

Study of fucosylated chondroitin sulfate from Cucumaria frondosa on hyperglycemic effects and insulin resistance improvement

Fucosylated Chondroitin Sulfate from Sea Cucumber in Combination with Rosiglitazone Improved Glucose Metabolism in the Liver of the Insulin-Resistant Mice.

Anti-Metabolic Syndrome Effects of Fucoidan from Fucus vesiculosus via Reactive Oxygen Species-Mediated Regulation of JNK, Akt, and AMPK Signaling

Fucosylated Chondroitin Sulfate from Acaudina Molpadioides Improves Hyperglycemia Via Activation of PKB/GLUT4 Signaling in Skeletal Muscle of Insulin Resistant Mice

Hypoglycemic property of acidic polysaccharide extracted from Saccharina japonica and its potential mechanism

In vitro and in vivo hypoglycemic effects of brown algal fucoidans

Fucosylated Chondroitin Sulfate from Sea Cucumber Improves Insulin Sensitivity Via Activation of PI3K/PKB Pathway.

Fucosylated Chondroitin Sulphate from Sea Cucumber Inhibits High-Fat-Sucrose Diet-Induced Apoptosis in Mouse Pancreatic Islets Via Down-Regulating Mitochondrial Signaling Pathway

Fucoidan from Ascophyllum Nodosum Suppresses Postprandial Hyperglycemia by Inhibiting Na+/Glucose Cotransporter 1 Activity.

Fucoidan from Laminaria japonica Ameliorates Type 2 Diabetes Mellitus in Association with Modulation of Gut Microbiota and Metabolites in Streptozocin-Treated Mice

Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice

Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes

The inhibition of chronic low-grade inflammation and the mechanism of fucoidan from Acaudina molpadioidea

Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota

Compared study of fucoidan from sea cucumber (<i>Holothuria tubulosa</i>) with different molecular weight on ameliorating cell apoptosis